Effect of autoimmune diseases on mortality and survival in subsequent digestive tract cancers

Annals of Oncology

Volumn 23, Issue 8, 2012, Pages 2179-2184

  Hemminki, K ^a,b   Liu, X ^b   Ji, J ^b   Sundquist, J ^a,c   Sundquist, K ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer mortality; Immune disease; Immunosuppression; Medication; Survival

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; CANCER MORTALITY; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; HAZARD RATIO; HUMAN; MYASTHENIA GRAVIS; PERNICIOUS ANEMIA; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; STANDARDIZED MORTALITY RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

EID: 84864931877     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr590     Document Type: Article

References (17)

1. Forabosco P, Bouzigon E, Ng MY et al. Meta-analysis of genome-wide linkage studies across autoimmune diseases. Eur J Hum Genet 2009; 17: 236-243.
2. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009; 10: 43-55.
3. Goldin LR, Landgren O Autoimmunity and lymphomagenesis. Int J Cancer 2009; 124: 1497-1502.
4. Brown LM, Gridley G, Check D, Landgren O. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008; 111: 3388-3394.
5. Landgren AM, Landgren O, Gridley G et al. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 2011; 117: 1163-1171.
6. Hemminki K, Liu X, Ji J et al. Autoimmune disease and subsequent digestive tract cancer by histology. Ann Oncol 2011; in press.
7. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009; 125: 1747-1754.
8. Rothwell PM, Fowkes FG, Belch JF et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377: 31-41.
9. Jensen AB, Larsen M, Gislum M et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol 2006; 101: 1283-1287.
10. Shu X, Ji J, Sundquist J et al. Survival in cancer patients hospitalized for psoriasis: a population-based cohort study in Sweden. Br J Dermatol 2011; 165: 129-136.
11. Shu X, Ji J, Sundquist K et al. Survival in cancer patients with previous hospitalization for sarcoidosis: a Swedish population-based cohort study during 1964-2006. Ann Oncol 2011; 22: 1427-1434.
12. Shu X, Ji J, Sundquist J et al. Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis 2011; 17: 816-822.
13. Ji J, Liu X, Sundquist K, Sundquist J. Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer. Rheumatology (Oxford) 2011; 50: 1513-1518.
14. Hemminki K, Li X, Sundquist K, Sundquist J. Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalizations in Sweden. J Epidemiol Community Health 2008; 62: 398-401.
15. Hemminki K, Li X, Sundquist K, Sundquist J. Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden. Clin Exp Allergy 2007; 37: 1320-1325.
16. Riihimaki M, Thomsen H, Brandt A et al. What do prostate cancer patients die of? Oncologist 2011; 16: 175-181.
17. Hemminki K, Santi I, Weires M et al. Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer 2011; 10: 688.